---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-025365"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T01:14:36.803329+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# FibroBiologics Amends Bylaws to Align with Universal Proxy Rules and DGCL Updates

## Summary
- Amended bylaws adopted June 25, 2024, clarifying procedural requirements under Rule 14a-19 universal proxy rules.
- Requires stockholders soliciting proxies to use a proxy card color other than white.
- Raised threshold for stockholder amendments of bylaws to 66 2/3% to align with the Certificate of Incorporation.
- Removed inconsistent provisions including ability of majority stockholders to remove directors without cause and call special meetings.
- Eliminated duplicative and obsolete provisions such as stock transfer restrictions from the direct listing.

## SEC filing metadata
- accession: 0001493152-24-025365
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315224025365/0001493152-24-025365-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315224025365/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-025365
- JSON: https://secwatch.observer/filing/0001493152-24-025365.json
- Plain text: https://secwatch.observer/filing/0001493152-24-025365.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.